Obeticolic acid
Sharaxaada
Obeticholic acid (INT-747) waa FXR xoog leh, door ah oo hadal firfircoon leh oo leh EC50 ee 99 nM.Obeticholic acid waxay leedahay saameyn anticholeretic iyo anti-bararka.Obeticholic acid sidoo kale waxay keentaa autophagy [1] [2] [3].
Asalkii hore
Obeticholic acid (6alpha-ethyl-chenodeoxycholic acid, 6-ECCDCA, INT-747) waa agonist awood leh oo xulashada FXR oo leh EC50 qiimaha 99 nM [1].
Farnesoid X reseptor (FXR) waa reseptors bile acid nukliyeer ah oo ku lug leh homeostasis bile acid homeostasis, beerka fibrosis, caabuqa beerka iyo xiidmaha iyo cudurada wadnaha [2].
Obeticholic acid waa agonist FXR awood leh oo door ah oo leh firfircoonida choleretic [1].Obeticholic Acid waa soosaar bile acid semisynthetic iyo ligand FXR awood leh.Jiirka cholestasis ee estrogen-ku keeno, 6-ECCDCA waxay ka ilaalisay cholestasis ay keentay 17a-ethynylestradiol (E217α) [2].Noocyada jiirka ee cirrhotic portal hypertension (PHT), INT-747 (30 mg/kg) waxay dib u kicisay dariiqa calaamadaynta FXR ee hoose waxayna hoos u dhigtay cadaadiska portal iyadoo hoos loo dhigayo wadarta iska caabbinta xididada xididada hepatic (IHVR) iyada oo aan lahayn hypotension nidaamsan.Saamayntan ayaa la xiriirta kororka dhaqdhaqaaqa eNOS [3].Qaabka Dahl rat ee dhiig-karka xasaasiga ah ee cusbada iyo iska caabbinta insulin-ta (IR), cuntada milixda badan (HS) waxay si weyn u kordhisay cadaadiska dhiigga ee nidaamka iyo muujinta unugyada hoos u dhaca ee DDAH.INT-747 waxay xoojisay dareenka insulin waxayna joojisay hoos u dhaca muujinta DDAH [4].
Tixraacyo:
[1]Pellicciari R, Fiorucci S, Camaioni E, iyo al.6alpha-ethyl-chenodeoxycholic acid (6-ECCDCA), FXR agonist xoog leh oo la xushay oo lagu siiyay waxqabadka anticholestatic.J Med Chem, 2002, 45 (17): 3569-3572.
[2].Fiorucci S, Clerici C, Antonelli E, iyo al.Saamaynta ilaalinta ee 6-ethyl chenodeoxycholic acid, ligand farnesoid X reseptor ligand, ee cholestasis uu keeno estrogen.J Pharmacol Exp Ther, 2005, 313 (2): 604-612.
[3]Verbeke L, Farre R, Trebicka J, iyo al.Obeticholic acid, farnesoid X reseptor agonist, waxay wanaajisaa hypertension portal laba dariiqo oo kala duwan ee jiirka cirrhotic.Hepatology, 2014, 59 (6): 2286-2298.
[4]Ghebremariam YT, Yamada K, Lee JC, iyo al.FXR agonist INT-747 waxay hagaajisaa muujinta DDAH waxayna xoojisaa dareenka insulin ee jiirka Dahl ee la quudiyo milix badan.PLoS One, 2013, 8 (4): e60653.
Tixraaca Alaabta
- 1. Selina Costa."Astaamaynta novel Ligand ee Farnesoid X soo dhaweynta iyadoo la adeegsanayo Zebrafish Transgenic."Jaamacadda Toronto.Jun-2018.
- 2. Kent, Rebecca."Saamaynta Fenofibrate ee CYP2D6 iyo Xeerarka ANG1 iyo RNASE4 ee FXR Agonist Obeticholic Acid."indigo.uic.edu.2017.
Kaydinta
Budada | -20°C | 3 sano |
4°C | 2 sano | |
Ku milmay | -80°C | 6 bilood |
-20°C | 1 bil |
Qaab dhismeedka kiimikada
Xogta Nafleyda ee La Xidhiidha
Xogta Nafleyda ee La Xidhiidha
Soo jeedin18Mashaariicda Qiimaynta Joogtada Tayada ee la ansixiyay4iyo6mashaariicda ayaa ku socda ansixinta.
Nidaamka maaraynta tayada sare ee caalamiga ah ayaa dhigay aasaas adag oo iib ah.
Kormeerka tayada wuxuu ku socdaa dhammaan wareegga nolosha ee alaabta si loo hubiyo tayada iyo saameynta daaweynta.
Kooxda Arrimaha Sharciyaynta Xirfadlayaasha waxay taageertaa shuruudaha tayada inta lagu jiro codsiga iyo diiwaangelinta.